Back to Trials
NCT03792659Recruiting

The EXPLORE MG Registry for Myasthenia Gravis

Yale University

Start Date

3/30/2016

Completion Date

10/30/2026

Summary

The purpose of this study is to create a Yale University Department of Neurology Myasthenia Gravis (MG) registry that will be used for current and future research projects involving the study of Myasthenia Gravis.

Detailed Description

This registry will allow for the research of several mechanisms of Myasthenia Gravis (MG) by studying peripheral blood, stool, disease status and course, and treatment of subjects with MG. The EXPLORE-MG Registry focuses on varied aspects of MG such as disease management, health care utilization, health costs, disease characteristics, and diagnostic tools. As such, it will aid in a broader understanding of MG, while providing a registry from which questions about the disease may be better answered.

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion Criteria: * Adult patients diagnosed with Myasthenia Gravis presenting to the Yale Department of Neurology for clinical care or research interventions will be invited to donate their biological specimens/clinical data. Exclusion Criteria: * Failure to meet the Inclusion Criteria.

Interventions

OTHER

Blood Sample Draw

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Myasthenia Gravis

Locations

Yale-New Haven Hospital

New Haven, Connecticut 06510

United States